echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The supplementary application for the consistent evaluation of Lansorazole for Jingfeng pharmaceutical injection has been formally accepted.

    The supplementary application for the consistent evaluation of Lansorazole for Jingfeng pharmaceutical injection has been formally accepted.

    • Last Update: 2020-10-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Developed by Takeda Pharmaceutical Co., Ltd. of Japan, lanso laazole for injection was first listed in Europe in December 1991 and approved for listing in Japan in December 1992.
    May 2004, the injectable lanso laazole developed by Takeda Pharmaceutical Industries Co., Ltd. of Japan was approved for listing by the U.S. Food and Drug Administration (the product was de-listed in the United States in February 2007).
    currently used in the injection of lansolazole original research drugs have not been listed in China.
    injections with lansolazole for oral therapy are not applicable to the following diseases: gastric ulcers with bleeding, heterosome ulcers, acute stress ulcers, acute gastric mucosal lesions.
    is a proton pump inhibitor.
    the drug is distributed in the acidic environment of the mucous membrane wall cells in the stomach and transformed into an active metabolite.
    this metabolite is combined with the -based binding of the H-, K-ATP enzyme present at the site of acid production, which inhibits acid secretion by inhibiting the activity of the H-, K-ATP enzyme.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.